ArticleJournal, genetic engineering & biotechnology2023

Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma.

Precious Ayorinde Akinnusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.